Introduction Emma Walmsley, the CEO of GlaxoSmithKline (GSK), represents a significant force in the pharmaceutical industry. Since taking on the role in April 2017, she has been instrumental in guiding the company through pivotal changes and challenges, especially in light of the ongoing COVID-19 pandemic. Her leadership style and strategic decisions have made her a
Introduction Emma Walmsley, CEO of GlaxoSmithKline (GSK), has emerged as a leading figure in the pharmaceutical industry, championing innovation and strategic growth. Her leadership comes at a pivotal time when the sector faces both challenges and opportunities, particularly in the wake of the COVID-19 pandemic that has reshaped global health perspectives. GSK’s Innovation Strategy Under